JXG
JX Luxventure Limited
There isn't enough reported data to score JXG yet.
LCID
Lucid Group, Inc.
LCID lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
JXG Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| Unavailable | |
| Healthy |
JXG's profitability and balance sheet are currently healthy. There isn't enough data to rate its revenue and cash flow.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
JXG PE Valuation
JXG has no meaningful PE right now: it lost money over the past year.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
JXG Forward outlook
There aren't enough analyst estimates for JXG to show an outlook.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
JXG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2021 | -$4,938.00 | -$3,684.00 |
| Q4 2020 | -$1,254.00 | -$1,254.00 |
| Q4 2019 | $0.00 | +$4,836.00 |
| Q4 2018 | -$4,836.00 | -$60.00 |
| Q4 2017 | -$4,776.00 | -$540.15 |
JXG has the edge over LCID in the latest year-over-year earnings comparison.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
JXG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2024 | $49.8M | +57% |
| Q4 2023 | $31.8M | -60% |
| Q4 2022 | $79.9M | +35% |
| Q4 2021 | $59M | +442% |
| Q4 2020 | $10.9M | -34% |
| Q4 2019 | $16.5M | +62% |
| Q4 2018 | $10.2M | -57% |
| Q4 2017 | $23.8M | +80% |
JXG has the edge over LCID in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2024 | 7.7% | +74 points |
| Q4 2023 | 9.6% | +7.1 points |
| Q4 2022 | -69% | +134 points |
| Q4 2021 | -33% | -2.7 points |
| Q4 2020 | -66% | +15 points |
| Q4 2019 | 2.5% | +50 points |
| Q4 2018 | -204% | -222 points |
| Q2 2018 | -31% | -36 points |
JXG's operating margin was 7.7% last quarter, up 74 points from the same quarter a year ago.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID's revenue has grown year over year for 11 quarters in a row: $350M last quarter, up 4.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
JXG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2024 | $7.3M | +$11.8M |
| Q4 2023 | -$4.5M | +$438.9K |
| Q4 2022 | -$5M | +$6.1M |
| Q4 2021 | -$11.1M | -$4.6M |
| Q4 2020 | -$6.5M | -$5.7M |
| Q4 2019 | -$828.8K | +$1.1M |
| Q4 2018 | -$1.9M | -296% |
| Q4 2017 | $975.4K | -21% |
JXG has burned cash in most quarters: −$13M over the past year, against −$11M the year before.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
JXG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +928% | +91.2K shares |
| 1 year | +2570% | +97.3K shares |
| 3 years | +39221% | +101K shares |
JXG has 101,054 diluted shares, up 2570% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2016 | — |
| Q3 2016 | — |
| Q2 2016 | — |
| Q1 2016 | — |
| Q4 2015 | — |
| Q3 2015 | — |
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has the edge over JXG on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
JXG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2024 | 0.1x | Very low |
| Q4 2023 | -2.3x | Net Cash |
| Q4 2019 | -17.9x | Net Cash |
| Q3 2016 | -3.6x | Net Cash |
| Q2 2016 | -3.9x | Net Cash |
JXG's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
JXG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 67.6 | Neutral |
| Stochastic | 68.6 | Neutral |
JXG's weekly RSI is 68 (neutral) and its Stochastic is 69 (neutral).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
JXG PE vs Consumer Cyclical Sector
JXG has no meaningful PE right now: it lost money over the past year.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
JXG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.25 | 59% above |
| 20 week MA | $8.43 | 55% above |
| 50 week MA | $6.72 | 95% above |
JXG has stronger trend alignment. JXG is above 3 of 3 weekly averages versus LCID above 0 of 5.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
JXG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $50.9 | $8.13 | -84% |
| 2026 YTD | $8.13 | $13.1 | +61% |
JXG has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.